CINELLI, FRANCESCO PIO
CINELLI, FRANCESCO PIO
Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence
2023-01-01 Barone, B; Finati, M; Cinelli, F; Fanelli, A; Del Giudice, F; De Berardinis, E; Sciarra, A; Russo, G; Mancini, V; D'Altilia, N; Ferro, M; Porreca, A; Chung, Bi; Basran, S; Bettocchi, C; Cormio, L; Imbimbo, C; Carrieri, G; Crocetto, F; Busetto, Gm.
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis
2022-01-01 Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis., Del Giudice F; Flammia, Rs; Chung, Bi; Moschini, M; Pradere, B; Mari, A; Soria, F; Albisinni, S; Krajewski, W; Szydełko, T; Laukhtina, E; D'Andrea, D; Gallioli, A; Mertens, Ls; Maggi, M; Sciarra, A; Salciccia, S; Ferro, M; Scornajenghi, Cm; Asero, V; Cattarino, S; De Angelis, M; Cacciamani, Ge; Autorino, R; Pandolfo, Sd; Falagario, Ug; D'Altilia, N; Mancini, V; Chirico, M; Cinelli, F; Bettocchi, C; Cormio, L; Carrieri, G; De Berardinis, E; Busetto, Gm
Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle?
2023-01-01 Busetto, Gm; Finati, M; Chirico, M; Cinelli, F; D'Altilia, N; Falagario, Ug; Sanguedolce, F; Del Giudice, F; De Berardinis, E; Ferro, M; Crocetto, F; Porreca, A; Di Gianfrancesco, L; Calo', B; Mancini, V; Bettocchi, C; Carrieri, G; Cormio, L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence | 1-gen-2023 | Barone, B; Finati, M; Cinelli, F; Fanelli, A; Del Giudice, F; De Berardinis, E; Sciarra, A; Russo, G; Mancini, V; D'Altilia, N; Ferro, M; Porreca, A; Chung, Bi; Basran, S; Bettocchi, C; Cormio, L; Imbimbo, C; Carrieri, G; Crocetto, F; Busetto, Gm. | |
| Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis | 1-gen-2022 | Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched Analysis., Del Giudice F; Flammia, Rs; Chung, Bi; Moschini, M; Pradere, B; Mari, A; Soria, F; Albisinni, S; Krajewski, W; Szydełko, T; Laukhtina, E; D'Andrea, D; Gallioli, A; Mertens, Ls; Maggi, M; Sciarra, A; Salciccia, S; Ferro, M; Scornajenghi, Cm; Asero, V; Cattarino, S; De Angelis, M; Cacciamani, Ge; Autorino, R; Pandolfo, Sd; Falagario, Ug; D'Altilia, N; Mancini, V; Chirico, M; Cinelli, F; Bettocchi, C; Cormio, L; Carrieri, G; De Berardinis, E; Busetto, Gm | |
| Conservative treatment for high-risk NMIBC failing BCG treatment: who benefits from adding electromotive drug administration (EMDA) of mitomycin C (MMC) to a second BCG induction cycle? | 1-gen-2023 | Busetto, Gm; Finati, M; Chirico, M; Cinelli, F; D'Altilia, N; Falagario, Ug; Sanguedolce, F; Del Giudice, F; De Berardinis, E; Ferro, M; Crocetto, F; Porreca, A; Di Gianfrancesco, L; Calo', B; Mancini, V; Bettocchi, C; Carrieri, G; Cormio, L. |